Overview

Dobutamine During Major Abdominal Surgery

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.
Phase:
NA
Details
Lead Sponsor:
University of Hamburg-Eppendorf
Treatments:
Dobutamine